Point72 Hong Kong LTD Repligen Corp Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $551,751 - $692,129	-3,059 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $452,976 - $631,897	3,059 New	3,059 $586,000
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $813,343 - $1.05 Million	-6,639 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $626,256 - $932,646	6,639 New	6,639 $821,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $78,672 - $101,063	-926 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $36,772 - $46,353	-498 Reduced 34.97%	926 $86,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $109,149 - $136,006	1,424 New	1,424 $109,000
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $3,252 - $5,157	-60 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $1,681 - $2,135	34 Added 130.77%	60 $4,000
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $1,254 - $1,790	26 New	26 $1,000
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $120,035 - $143,614	-3,690 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $136,456 - $169,961	3,690	3,690 $141,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.